Target intelligence / Profile preview

Ferrous iron and redox-active metal ions (Fe2+)

Target
Fe2+
Molecular classification
Metal ion, Inorganic cofactor
01

Overview

Ferrous iron (Fe2+) and other redox-active metal ions, such as copper (Cu+), are essential trace elements that serve as critical cofactors for enzymes involved in oxygen transport, DNA synthesis, and mitochondrial electron transport (Source: PubMed, PMID: 29374220). However, when these ions exist in a 'labile' or unbound state, they can catalyze the formation of highly reactive hydroxyl radicals via the Fenton reaction, leading to lipid peroxidation and a specific form of regulated cell death known as ferroptosis (Source: Nature Reviews Molecular Cell Biology). Pathological accumulation of these metals is a hallmark of several conditions, including hereditary hemochromatosis, transfusion-dependent thalassemia, and Wilson's disease. In clinical practice, these ions are targeted by chelating agents that bind the metal to facilitate its excretion or neutralize its redox activity. Beyond classic metal overload syndromes, the modulation of redox-active metals is an area of intense research for neurodegenerative disorders like Alzheimer's and Parkinson's diseases, where metal dysregulation contributes to protein aggregation and oxidative damage (Source: NIH, 'Iron and Neurodegeneration'). Therapeutic strategies aim to balance the necessity of these metals for cellular function with the prevention of their toxic, pro-oxidant effects.

Other names
Labile iron poolFe(II)Divalent metal ionsTransition metal ionsFree ironRedox-active metals
02

Mechanism of action

Chelation of metal ions to form stable, water-soluble complexes that are subsequently excreted via the kidneys or bile, thereby preventing the generation of reactive oxygen species (ROS) through Fenton and Haber-Weiss chemistry (Source: StatPearls, 'Chelating Agents').

03

Biological functions

Oxygen transportElectron transferDNA synthesisRedox signalingCellular respirationFerroptosis
04

Disease associations

Iron overloadHemochromatosisThalassemiaNeurodegenerative diseaseWilson's diseaseCancerIschemia-reperfusion injury
05

Safety considerations

Depletion of essential trace minerals (e.g., zinc, copper)NephrotoxicityAgranulocytosis (specifically with Deferiprone)Gastrointestinal distressOcular and auditory toxicity
06

Interacting drugs

Deferoxamine

5 more in the full profile.

07

Biomarkers

Serum ferritinTransferrin saturationLabile iron pool (LIP)Urinary metal excretionLiver iron concentration (LIC)

Beyond the preview

Go deeper on Ferrous iron and redox-active metal ions (Fe2+).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ferrous iron and redox-active metal ions (Fe2+).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call